• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

GoodRx teams with Boehringer on Humira biosimilar

cafead

Administrator
Staff member
  • cafead   Jul 18, 2024 at 11:33: AM
via A new partnership between prescription savings platform GoodRx and drugmaker Boehringer Ingelheim will make the company's Humira knockoff available for a discounted cash pay price of $550.

article source